Report From the Jerusalem Workshop on Lynch Syndrome-Hereditary Nonpolyposis Colorectal Cancer

Gastroenterology

Volumn 138, Issue 7, 2010, Pages 2197.e1-2197.e7

  Boland, C Richard ^a   Shike, Moshe ^b  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FLUOROURACIL; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MISMATCH REPAIR PROTEIN PMS2; NOVELOSE; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; STARCH; UNCLASSIFIED DRUG;

ADENOMA; ARTICLE; BRAIN CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CLINICAL FEATURE; COLON CANCER; COLORECTAL TUMOR; DIGESTIVE SYSTEM CANCER; ENDOMETRIUM CANCER; GENE LOCUS; GENE MUTATION; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; ISRAEL; MUIR TORRE SYNDROME; MUTATION RATE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DNA INTERACTION; RECTUM CANCER; SEBACEOUS GLAND TUMOR; STOMACH CANCER; SYSTEMIC THERAPY; WORKSHOP;

EID: 77952681872     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.04.024     Document Type: Article

References (31)

1. Hampel H., Frankel W.L., Martin E., et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352 (2005) 1851-1860
2. Hampel H., Frankel W., Panescu J., et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66 (2006) 7810-7817
3. Hampel H., Panescu J., Lockman J., et al. Comment on: Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 67 (2007) 9603
4. Hampel H., Frankel W.L., Martin E., et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26 (2008) 5783-5788
5. Barnetson R.A., Tenesa A., Farrington S.M., et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354 (2006) 2751-2763
6. Kastrinos F., Mukherjee B., Tayob N., et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302 (2009) 1790-1795
7. Vasen H.F., Stormorken A., Menko F.H., et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19 (2001) 4074-4080
8. Watson P., Vasen H.F., Mecklin J.P., et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123 (2008) 444-449
9. Shia J., Ellis N.A., Paty P.B., et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 27 (2003) 1407-1417
10. Peltomaki P., and Vasen H. Mutations associated with HNPCC predisposition-update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 20 (2004) 269-276
11. Woods M.O., Williams P., Careen A., et al. A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 28 (2007) 669-673
12. Hitchins M.P., and Ward R.L. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer. J Med Genet 46 (2009) 793-802
13. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248-5257
14. Umar A., Boland C.R., Terdiman J.P., et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 (2004) 261-268
15. Duval A., and Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res 62 (2002) 2447-2454
16. Markowitz S., Wang J., Myeroff L., et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268 (1995) 1336-1338
17. Rampino N., Yamamoto H., Ionov Y., et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275 (1997) 967-969
18. Chang D.K., Metzgar D., Wills C., et al. Microsatellites in the eukaryotic DNA mismatch repair genes as modulators of evolutionary mutation rate. Genome Res 11 (2001) 1145-1146
19. Haugen A.C., Goel A., Yamada K., et al. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer. Cancer Res 68 (2008) 8465-8472
20. Capelle L.G., Van Grieken N.T., Lingsma H.F., et al. Risk and epidemiological time trends of gastric cancer in Lynch Syndrome carriers in The Netherlands. Gastroenterology 138 (2010) 487-492
21. Pages F., Berger A., Camus M., et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353 (2005) 2654-2666
22. Galon J., Costes A., Sanchez-Cabo F., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313 (2006) 1960-1964
23. Galon J., Fridman W.H., and Pages F. The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. Cancer Res 67 (2007) 1883-1886
24. Burn J., Bishop D.T., Mecklin J.P., et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 359 (2008) 2567-2578
25. Balmana J., Stockwell D.H., Steyerberg E.W., et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 296 (2006) 1469-1478
26. Chen S., Wang W., Lee S., et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296 (2006) 1479-1487
27. Balmana J., Balaguer F., Castellvi-Bel S., et al. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet 45 (2008) 557-563
28. Balaguer F., Balmana J., Castellvi-Bel S., et al. Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology 134 (2008) 39-46
29. Pinol V., Castells A., Andreu M., et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293 (2005) 1986-1994
30. Bessa X., Balleste B., Andreu M., et al. A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening. Clin Gastroenterol Hepatol 6 (2008) 206-214
31. Paya A., Alenda C., Perez-Carbonell L., et al. Utility of p16 immunohistochemistry for the identification of Lynch syndrome. Clin Cancer Res 15 (2009) 3156-3162